Patty P. Kaewussdangkul

FDA investigator · also recorded as P. Kaewussdangkul

Appears on 54 documents from 2006 to 2026, mostly at sites in Texas. Most often cites control of microbiological contamination (21 CFR 211.113).

54
Documents on file
5.6
Observations per 483
2006
First seen
2026
Most recent

What they cite most

From 301 observations

Activity by year

2006: 1, 2013: 1, 2015: 2, 2016: 4, 2017: 3, 2018: 4, 2019: 8, 2020: 3, 2021: 5, 2022: 7, 2023: 7, 2024: 6, 2025: 2, 2026: 1

Where

Texas 34 · India 7 · China 4 · Florida 2 · Japan 2 · Canada 1

Is Patty P. Kaewussdangkul coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

54 documents, newest first
FirmOpen
483 Eugia Pharma Specialities LimitedFeb 6, 2026 · Sangareddy, India
483 DR REDDY'S LABORATORIES LIMITEDJul 18, 2025 · Srikakulam, India
483 Pillar5 Pharma IncFeb 7, 2025 · Arnprior, Canada
483 Yiling Pharmaceutical LtdOct 11, 2024 · Shijiazhuang, China
483 Jiangsu Anbison Pharmaceutical Co., Ltd.Jul 16, 2024 · Taizhou, China
483 Mylan Laboratories LimitedMay 17, 2024 · Hosur, India
483 Otsuka Pharmaceutical Co., Ltd.Mar 22, 2024 · Tokushima, Japan

About this profile

What does Patty P. Kaewussdangkul inspect?

Patty P. Kaewussdangkul appears on 54 documents on file covering 46 sites, mostly in Texas.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Patty P. Kaewussdangkul is dated Feb 6, 2026.